Publications by authors named "Alain Spatz"

Claim this Profile
S
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.
Jean Philippe Arnault, Christine Mateus, Bernard Escudier, Gorana Tomasic, Janine Wechsler, Alain Spatz

Clin Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).
Poulam M Patel, Stefan Suciu, Laurent Mortier, Wim H Kruit, Caroline Robert, Alain Spatz

Eur J Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.
Augustinus P T van der Ploeg, Alexander C J van Akkooi, Piotr Rutkowski, Zbigniew I Nowecki, Wanda Michej, Alain Spatz

J Clin Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991.
Marna G Bouwhuis, Stefan Suciu, Alessandro Testori, Wim H Kruit, François Salès, Alain Spatz

J Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline.
Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saiag, Mark Middleton, Alain Spatz

Eur J Cancer· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden.
Alexander C J van Akkooi, Alain Spatz, Alexander M M Eggermont, Martin Mihm, Martin G Cook

Eur J Cancer· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.
Annette H Chakera, Birger Hesse, Zeynep Burak, James R Ballinger, Allan Britten, Alain Spatz

Eur J Nucl Med Mol Imaging· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib.
Jean Philippe Arnault, Janine Wechsler, Bernard Escudier, Alain Spatz, Gorana Tomasic

J Clin Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group.
Andrew Bottomley, Corneel Coens, Stefan Suciu, Mario Santinami, Willem Kruit, Alain Spatz

J Clin Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.
Marna G Bouwhuis, Stefan Suciu, Sandra Collette, Steinar Aamdal, Wim H Kruit, Alain Spatz

J Natl Cancer Inst· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatologic symptoms associated with the multikinase inhibitor sorafenib.
Caroline Robert, Christina Mateus, Alain Spatz, Janine Wechsler, Bernard Escudier

J Am Acad Dermatol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective expression of inhibitory Fcgamma receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response.
Lydie Cassard, Joel F G Cohen-Solal, Emilie M Fournier, Sophie Camilleri-Broët, Alain Spatz

Int J Cancer· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.
Alexander Mm Eggermont, Stefan Suciu, Mario Santinami, Alessandro Testori, Wim Hj Kruit, Alain Spatz

Lancet· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.
Julien Autier, Bernard Escudier, Janine Wechsler, Alain Spatz, Caroline Robert

Arch Dermatol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas.
Caroline Kannengiesser, Alain Spatz, Stefan Michiels, Alain Eychène, Philippe Dessen

Mol Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Christian Monnerat, Agnès Chompret, Caroline Kannengiesser, Marie-Françoise Avril, Nicolas Janin, Alain Spatz

Fam Cancer· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression profiling of melanoma cell lines: in search of a progression-related molecular signature.
Joost J Van den Oord, Alain Sarasin, Vèronique Winnepenninckx, Alain Spatz

Future Oncol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma.
Bruce Elliott, Richard A Scolyer, Stefan Suciu, Serge Lebecque, Donata Rimoldi, Alain Spatz

Clin Cancer Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Eve Maubec, Jean Lumbroso, Florence Masson, Voichita Suciu, Frédéric Kolb, Alain Spatz

Melanoma Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.
Sophie Queille, Lionel Luron, Alain Spatz, Marie Françoise Avril, Vincent Ribrag

Carcinogenesis· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma.
Véronique Winnepenninckx, Maria Debiec-Rychter, Jeroen A M Beliën, Pierre Fiten, Stefan Michiels, Alain Spatz

Mod Pathol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell derived-exosomes: biology and clinical implementations.
Nathalie Chaput, Caroline Flament, Sophie Viaud, Julien Taieb, Stephan Roux, Alain Spatz

J Leukoc Biol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Véronique Winnepenninckx, Vladimir Lazar, Stefan Michiels, Philippe Dessen, Marguerite Stas, Alain Spatz

J Natl Cancer Inst· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5 year follow-up period.
Nathalie Lassau, Michele Lamuraglia, Serge Koscielny, Alain Spatz, Alain Roche

Cancer Imaging· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors to keep in mind when introducing virtual microscopy.
Katharina Glatz-Krieger, Udo Spornitz, Alain Spatz, Michael J Mihatsch, Dieter Glatz

Virchows Arch· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis